On August 28, 2024 Chemomab Therapeutics Ltd. (Nasdaq: CMMB) (Chemomab), a clinical stage biotechnology company developing innovative therapeutics for fibro-inflammatory diseases with high unmet need, reported that Chief Executive Officer Dr. Adi Mor will deliver corporate presentations at the H.C. Wainwright 26th Annual Global Investment Conference and at the HBM Biopharma Summit 2024 in Zurich, Switzerland (Press release, Chemomab, AUG 28, 2024, View Source [SID1234646150]). Dr. Mor’s prerecorded H.C. Wainwright presentation will be webcast and is available starting on September 9, 2024 at 7:00 am ET. The link to access the webcast is included below and is also available at the Events section of the Chemomab website. Dr. Mor’s live presentation at the HBM Biopharma Summit is scheduled at 10:45 am CET on September 23, 2024. Company presentations at the HBM Summit will not be webcast.
Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:
Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing
Schedule Your 30 min Free Demo!
Chemomab Presentation at 2024 H.C. Wainwright 26th Annual Global Investment Conference
Date: September 9, 2024
Time: Available starting at 7:00 am ET for 90 days
Venue: Virtual
Format: Prerecorded webcast presentation
Webcast Link: View Source
Chemomab Presentation at HBM Biopharma Summit 2024
Date: September 23, 2024
Time: 10:45 am CET
Venue: Park Hyatt Zurich
Format: Live in person presentation
Information: View Source